Skip to main content
Top
Published in: Respiratory Research 1/2018

Open Access 01-12-2018 | Research

Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation

Authors: Anna Winkler, Kathrin Kahnert, Jürgen Behr, Claus Neurohr, Nikolaus Kneidinger, Rudolf Hatz, Holger Dressel, Thomas Radtke, Rudolf A. Jörres

Published in: Respiratory Research | Issue 1/2018

Login to get access

Abstract

Background

There is a need for non-invasive parameters that are sensitive to the development of the bronchiolitis obliterans syndrome (BOS) in lung transplantation (LTx) patients. We studied whether the pulmonary diffusing capacity for inhaled nitric oxide is capable of detecting BOS stages.

Methods

Sixty-one LTx patients were included into this cross-sectional study (19/29/7/3/3 in BOS stages 0/0-p/1/2/3). For analysis stages 0/0-p versus 1/2/3 (“BOS binary-early”), and stages 0/0-p/1 versus 2/3 (“BOS binary-late”) were summarized. Measurements of the combined diffusing capacity for nitric oxide (DLNO) and carbon monoxide (DLCO) were compared with spirometry and bodyplethysmography, and their relative importance was evaluated by discriminant analysis.

Results

Regarding the recognition of “BOS binary-early”, among spirometric parameters forced expiratory volume in 1 s (FEV1) was best, among bodyplethysmographic parameters airway resistance, and among diffusing parameters DLNO. Regarding “BOS binary-late”, DLNO was inferior to bodyplethysmographic parameters.

Conclusion

Although the study comprised only measurements at a single time point and no follow-up, DLNO outperformed FEV1, the time course of which is used in detecting BOS. Together with its pathophysiological plausibility, this result suggests that the measurement of DLNO, possibly over time, could be an easily applicable tool for the monitoring of LTx patients and should be evaluated in larger studies.
Literature
1.
go back to reference Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K, Levvey BJ, Lund LH, Meiser B, Rossano JW, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. J Heart Lung Transplant. 2017;36(10):1047–59.CrossRefPubMed Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K, Levvey BJ, Lund LH, Meiser B, Rossano JW, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. J Heart Lung Transplant. 2017;36(10):1047–59.CrossRefPubMed
2.
go back to reference Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb SB, Levvey BJ, Lund LH, Meiser B, Rossano JW, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report--2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant. 2015;34(10):1264–77.CrossRefPubMed Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb SB, Levvey BJ, Lund LH, Meiser B, Rossano JW, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report--2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant. 2015;34(10):1264–77.CrossRefPubMed
3.
go back to reference Royer PJ, Olivera-Botello G, Koutsokera A, Aubert JD, Bernasconi E, Tissot A, Pison C, Nicod L, Boissel JP, Magnan A, et al. Chronic Lung Allograft Dysfunction: A Systematic Review of Mechanisms. Transplantation. 2016;100(9):1803–14.CrossRefPubMed Royer PJ, Olivera-Botello G, Koutsokera A, Aubert JD, Bernasconi E, Tissot A, Pison C, Nicod L, Boissel JP, Magnan A, et al. Chronic Lung Allograft Dysfunction: A Systematic Review of Mechanisms. Transplantation. 2016;100(9):1803–14.CrossRefPubMed
5.
go back to reference Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, Hachem R, Hayes D, Jr., Neil D, Reinsmoen NL et al.: Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2016, 35(4):397–406. Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, Hachem R, Hayes D, Jr., Neil D, Reinsmoen NL et al.: Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2016, 35(4):397–406.
6.
go back to reference Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, Wagnetz D, Chaparro C, Singer LG, Hutcheon MA, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant. 2011;30(7):735–42.CrossRefPubMed Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, Wagnetz D, Chaparro C, Singer LG, Hutcheon MA, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant. 2011;30(7):735–42.CrossRefPubMed
7.
go back to reference Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002;21(3):297–310.CrossRefPubMed Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002;21(3):297–310.CrossRefPubMed
8.
go back to reference Yousem SA, Duncan SR, Griffith BP. Interstitial and airspace granulation tissue reactions in lung transplant recipients. Am J Surg Pathol. 1992;16(9):877–84.CrossRefPubMed Yousem SA, Duncan SR, Griffith BP. Interstitial and airspace granulation tissue reactions in lung transplant recipients. Am J Surg Pathol. 1992;16(9):877–84.CrossRefPubMed
9.
go back to reference Verleden SE, Sacreas A, Vos R, Vanaudenaerde BM, Verleden GM. Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation. Chest. 2016;150(1):219–25.CrossRefPubMed Verleden SE, Sacreas A, Vos R, Vanaudenaerde BM, Verleden GM. Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation. Chest. 2016;150(1):219–25.CrossRefPubMed
10.
go back to reference Kneidinger N, Milger K, Janitza S, Ceelen F, Leuschner G, Dinkel J, Konigshoff M, Weig T, Schramm R, Winter H et al.: Lung volumes predict survival in patients with chronic lung allograft dysfunction. Eur Respir J 2017, 49(4). Kneidinger N, Milger K, Janitza S, Ceelen F, Leuschner G, Dinkel J, Konigshoff M, Weig T, Schramm R, Winter H et al.: Lung volumes predict survival in patients with chronic lung allograft dysfunction. Eur Respir J 2017, 49(4).
11.
go back to reference Neurohr C, Huppmann P, Leuschner S, von Wulffen W, Meis T, Leuchte H, Ihle F, Zimmermann G, Baezner C, Hatz R, et al. Usefulness of exhaled nitric oxide to guide risk stratification for bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant. 2011;11(1):129–37.CrossRefPubMed Neurohr C, Huppmann P, Leuschner S, von Wulffen W, Meis T, Leuchte H, Ihle F, Zimmermann G, Baezner C, Hatz R, et al. Usefulness of exhaled nitric oxide to guide risk stratification for bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant. 2011;11(1):129–37.CrossRefPubMed
12.
go back to reference Cameli P, Bargagli E, Fossi A, Bennett D, Voltolini L, Refini RM, Gotti G, Rottoli P. Exhaled nitric oxide and carbon monoxide in lung transplanted patients. Respir Med. 2015;109(9):1224–9.CrossRefPubMed Cameli P, Bargagli E, Fossi A, Bennett D, Voltolini L, Refini RM, Gotti G, Rottoli P. Exhaled nitric oxide and carbon monoxide in lung transplanted patients. Respir Med. 2015;109(9):1224–9.CrossRefPubMed
13.
go back to reference Zavorsky GS, Hsia CC, Hughes JM, Borland CD, Guenard H, van der Lee I, Steenbruggen I, Naeije R, Cao J, Dinh-Xuan AT. Standardisation and application of the single-breath determination of nitric oxide uptake in the lung. Eur Respir J. 2017:49(2). Zavorsky GS, Hsia CC, Hughes JM, Borland CD, Guenard H, van der Lee I, Steenbruggen I, Naeije R, Cao J, Dinh-Xuan AT. Standardisation and application of the single-breath determination of nitric oxide uptake in the lung. Eur Respir J. 2017:49(2).
14.
go back to reference Nyilas S, Carlens J, Price T, Singer F, Muller C, Hansen G, Warnecke G, Latzin P, Schwerk N. Multiple breath washout in pediatric patients after lung transplantation. Am J Transplant. 2018;18(1):145–53.CrossRefPubMed Nyilas S, Carlens J, Price T, Singer F, Muller C, Hansen G, Warnecke G, Latzin P, Schwerk N. Multiple breath washout in pediatric patients after lung transplantation. Am J Transplant. 2018;18(1):145–53.CrossRefPubMed
15.
16.
go back to reference Guenard H, Varene N, Vaida P. Determination of lung capillary blood volume and membrane diffusing capacity in man by the measurements of NO and CO transfer. Respir Physiol. 1987;70(1):113–20.CrossRefPubMed Guenard H, Varene N, Vaida P. Determination of lung capillary blood volume and membrane diffusing capacity in man by the measurements of NO and CO transfer. Respir Physiol. 1987;70(1):113–20.CrossRefPubMed
17.
go back to reference Borland C, Bottrill F, Jones A, Sparkes C, Vuylsteke A. The significant blood resistance to lung nitric oxide transfer lies within the red cell. J Appl Physiol (1985). 2014;116(1):32–41.CrossRef Borland C, Bottrill F, Jones A, Sparkes C, Vuylsteke A. The significant blood resistance to lung nitric oxide transfer lies within the red cell. J Appl Physiol (1985). 2014;116(1):32–41.CrossRef
18.
go back to reference van der Lee I, Zanen P, Biesma DH, van den Bosch JM. The effect of red cell transfusion on nitric oxide diffusing capacity. Respiration. 2005;72(5):512–6.CrossRefPubMed van der Lee I, Zanen P, Biesma DH, van den Bosch JM. The effect of red cell transfusion on nitric oxide diffusing capacity. Respiration. 2005;72(5):512–6.CrossRefPubMed
19.
go back to reference Hughes JM, van der Lee I. The TL,NO/TL,CO ratio in pulmonary function test interpretation. Eur Respir J. 2013;41(2):453–61.CrossRefPubMed Hughes JM, van der Lee I. The TL,NO/TL,CO ratio in pulmonary function test interpretation. Eur Respir J. 2013;41(2):453–61.CrossRefPubMed
21.
go back to reference Dressel H, Filser L, Fischer R, de la Motte D, Steinhaeusser W, Huber RM, Nowak D, Jorres RA. Lung diffusing capacity for nitric oxide and carbon monoxide: dependence on breath-hold time. Chest. 2008;133(5):1149–54.CrossRefPubMed Dressel H, Filser L, Fischer R, de la Motte D, Steinhaeusser W, Huber RM, Nowak D, Jorres RA. Lung diffusing capacity for nitric oxide and carbon monoxide: dependence on breath-hold time. Chest. 2008;133(5):1149–54.CrossRefPubMed
22.
go back to reference Dressel H, Filser L, Fischer R, Marten K, Muller-Lisse U, de la Motte D, Nowak D, Huber RM, Jorres RA. Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis. BMC Pulm Med. 2009;9:30.CrossRefPubMedPubMedCentral Dressel H, Filser L, Fischer R, Marten K, Muller-Lisse U, de la Motte D, Nowak D, Huber RM, Jorres RA. Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis. BMC Pulm Med. 2009;9:30.CrossRefPubMedPubMedCentral
23.
go back to reference Zavorsky GS. Nitric oxide uptake in the lung: It is about time that clinicians use this test routinely. Respir Physiol Neurobiol. 2017;241:1–2.CrossRefPubMed Zavorsky GS. Nitric oxide uptake in the lung: It is about time that clinicians use this test routinely. Respir Physiol Neurobiol. 2017;241:1–2.CrossRefPubMed
24.
go back to reference Roughton FJ, Forster RE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol. 1957;11(2):290–302.CrossRefPubMed Roughton FJ, Forster RE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol. 1957;11(2):290–302.CrossRefPubMed
25.
go back to reference Criee CP, Sorichter S, Smith HJ, Kardos P, Merget R, Heise D, Berdel D, Kohler D, Magnussen H, Marek W, et al. Body plethysmography--its principles and clinical use. Respir Med. 2011;105(7):959–71.CrossRefPubMed Criee CP, Sorichter S, Smith HJ, Kardos P, Merget R, Heise D, Berdel D, Kohler D, Magnussen H, Marek W, et al. Body plethysmography--its principles and clinical use. Respir Med. 2011;105(7):959–71.CrossRefPubMed
26.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P et al: Standardisation of spirometry. Eur Respir J 2005, 26(2):319–338. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P et al: Standardisation of spirometry. Eur Respir J 2005, 26(2):319–338.
27.
go back to reference Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–43.CrossRefPubMedPubMedCentral Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–43.CrossRefPubMedPubMedCentral
28.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5–40.CrossRefPubMed Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5–40.CrossRefPubMed
29.
go back to reference Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.CrossRefPubMedPubMedCentral Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.CrossRefPubMedPubMedCentral
30.
go back to reference Schuba B, Scheklinski M, von Dossow V, Schneider C, Preissler G, Kneidinger N, Neurohr C, Michel S, Hagl C, Schramm R: Five-year experience using the Lung Allocation Score: the Munich Lung Transplant Group. Eur J Cardiothorac Surg 201854(2):328-333. Schuba B, Scheklinski M, von Dossow V, Schneider C, Preissler G, Kneidinger N, Neurohr C, Michel S, Hagl C, Schramm R: Five-year experience using the Lung Allocation Score: the Munich Lung Transplant Group. Eur J Cardiothorac Surg 201854(2):328-333.
31.
go back to reference van der Lee I, van Es HW, Noordmans HJ, van den Bosch JM, Zanen P. Alveolar volume determined by single-breath helium dilution correlates with the high-resolution computed tomography-derived nonemphysematous lung volume. Respiration. 2006;73(4):468–73.CrossRefPubMed van der Lee I, van Es HW, Noordmans HJ, van den Bosch JM, Zanen P. Alveolar volume determined by single-breath helium dilution correlates with the high-resolution computed tomography-derived nonemphysematous lung volume. Respiration. 2006;73(4):468–73.CrossRefPubMed
32.
go back to reference Stanojevic S, Graham BL, Cooper BG, Thompson BR, Carter KW, Francis RW, Hall GL. Global Lung Function Initiative Twg, Global Lung Function Initiative T: Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J. 2017;50(3):139-43. Stanojevic S, Graham BL, Cooper BG, Thompson BR, Carter KW, Francis RW, Hall GL. Global Lung Function Initiative Twg, Global Lung Function Initiative T: Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J. 2017;50(3):139-43.
33.
go back to reference Radtke T, Benden C, Maggi-Beba M, Kriemler S, van der Lee I, Dressel H. Intra-session and inter-session variability of nitric oxide pulmonary diffusing capacity in adults with cystic fibrosis. Respir Physiol Neurobiol. 2017;246:33–8.CrossRefPubMed Radtke T, Benden C, Maggi-Beba M, Kriemler S, van der Lee I, Dressel H. Intra-session and inter-session variability of nitric oxide pulmonary diffusing capacity in adults with cystic fibrosis. Respir Physiol Neurobiol. 2017;246:33–8.CrossRefPubMed
34.
go back to reference Magini A, Apostolo A, Salvioni E, Italiano G, Veglia F, Agostoni P. Alveolar-capillary membrane diffusion measurement by nitric oxide inhalation in heart failure. Eur J Prev Cardiol. 2015;22(2):206–12.CrossRefPubMed Magini A, Apostolo A, Salvioni E, Italiano G, Veglia F, Agostoni P. Alveolar-capillary membrane diffusion measurement by nitric oxide inhalation in heart failure. Eur J Prev Cardiol. 2015;22(2):206–12.CrossRefPubMed
35.
go back to reference Degano B, Mittaine M, Guenard H, Rami J, Garcia G, Kamar N, Bureau C, Peron JM, Rostaing L, Riviere D. Nitric oxide and carbon monoxide lung transfer in patients with advanced liver cirrhosis. J Appl Physiol (1985). 2009;107(1):139–43.CrossRef Degano B, Mittaine M, Guenard H, Rami J, Garcia G, Kamar N, Bureau C, Peron JM, Rostaing L, Riviere D. Nitric oxide and carbon monoxide lung transfer in patients with advanced liver cirrhosis. J Appl Physiol (1985). 2009;107(1):139–43.CrossRef
36.
go back to reference Farha S, Laskowski D, George D, Park MM, Tang WH, Dweik RA, Erzurum SC. Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension. Respir Res. 2013;14:6.CrossRefPubMedPubMedCentral Farha S, Laskowski D, George D, Park MM, Tang WH, Dweik RA, Erzurum SC. Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension. Respir Res. 2013;14:6.CrossRefPubMedPubMedCentral
37.
go back to reference van der Lee I, Gietema HA, Zanen P, van Klaveren RJ, Prokop M, Lammers JW, van den Bosch JM. Nitric oxide diffusing capacity versus spirometry in the early diagnosis of emphysema in smokers. Respir Med. 2009;103(12):1892–7.CrossRefPubMed van der Lee I, Gietema HA, Zanen P, van Klaveren RJ, Prokop M, Lammers JW, van den Bosch JM. Nitric oxide diffusing capacity versus spirometry in the early diagnosis of emphysema in smokers. Respir Med. 2009;103(12):1892–7.CrossRefPubMed
38.
go back to reference Le Bourgeois A, Malard F, Chevallier P, Urbistandoy G, Guillaume T, Delaunay J, Peterlin P, Lemarchand P, Germaud P, Mohty M, et al. Impact of pre-transplant diffusion lung capacity for nitric oxide (DLNO) and of DLNO/pre-transplant diffusion lung capacity for carbon monoxide (DLNO/DLCO) ratio on pulmonary outcomes in adults receiving allogeneic stem cell transplantation for hematological diseases. Bone Marrow Transplant. 2016;51(4):589–92.CrossRefPubMed Le Bourgeois A, Malard F, Chevallier P, Urbistandoy G, Guillaume T, Delaunay J, Peterlin P, Lemarchand P, Germaud P, Mohty M, et al. Impact of pre-transplant diffusion lung capacity for nitric oxide (DLNO) and of DLNO/pre-transplant diffusion lung capacity for carbon monoxide (DLNO/DLCO) ratio on pulmonary outcomes in adults receiving allogeneic stem cell transplantation for hematological diseases. Bone Marrow Transplant. 2016;51(4):589–92.CrossRefPubMed
Metadata
Title
Combined diffusing capacity for nitric oxide and carbon monoxide as predictor of bronchiolitis obliterans syndrome following lung transplantation
Authors
Anna Winkler
Kathrin Kahnert
Jürgen Behr
Claus Neurohr
Nikolaus Kneidinger
Rudolf Hatz
Holger Dressel
Thomas Radtke
Rudolf A. Jörres
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2018
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-018-0881-1

Other articles of this Issue 1/2018

Respiratory Research 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.